|
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.sz) Valoración de DCF
CN | Healthcare | Biotechnology | SHZ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) Bundle
¡Descubra el verdadero potencial del Tíbet Cheezheng Tibetan Medicine Co., Ltd. (002287SZ) con nuestra calculadora DCF premium! Ajuste los supuestos clave, explore varios escenarios y evalúe cómo influyen los cambios en la valoración del Tíbet Cheezheng Tibetan Medicine Co., Ltd. (002287SZ), todo dentro de una conveniente plantilla de Excel.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,402.7 | 1,476.2 | 1,770.5 | 2,044.8 | 2,010.3 | 2,206.2 | 2,421.3 | 2,657.2 | 2,916.2 | 3,200.4 |
| Revenue Growth, % | 0 | 5.24 | 19.93 | 15.49 | -1.69 | 9.75 | 9.75 | 9.75 | 9.75 | 9.75 |
| EBITDA | 442.3 | 509.7 | 617.2 | 721.1 | 805.1 | 777.6 | 853.4 | 936.6 | 1,027.9 | 1,128.1 |
| EBITDA, % | 31.53 | 34.53 | 34.86 | 35.27 | 40.05 | 35.25 | 35.25 | 35.25 | 35.25 | 35.25 |
| Depreciation | 36.1 | 43.8 | 66.5 | 85.9 | 95.8 | 80.6 | 88.5 | 97.1 | 106.5 | 116.9 |
| Depreciation, % | 2.57 | 2.97 | 3.76 | 4.2 | 4.76 | 3.65 | 3.65 | 3.65 | 3.65 | 3.65 |
| EBIT | 406.2 | 465.9 | 550.7 | 635.2 | 709.3 | 697.0 | 765.0 | 839.5 | 921.4 | 1,011.2 |
| EBIT, % | 28.96 | 31.56 | 31.1 | 31.06 | 35.28 | 31.59 | 31.59 | 31.59 | 31.59 | 31.59 |
| Total Cash | 1,379.0 | 1,829.9 | 1,850.6 | 1,976.9 | 2,366.5 | 2,184.1 | 2,397.0 | 2,630.6 | 2,887.0 | 3,168.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 678.3 | 1,024.3 | 844.2 | 850.5 | 604.9 | 1,046.2 | 1,148.2 | 1,260.1 | 1,382.9 | 1,517.7 |
| Account Receivables, % | 48.36 | 69.38 | 47.68 | 41.59 | 30.09 | 47.42 | 47.42 | 47.42 | 47.42 | 47.42 |
| Inventories | 62.0 | 94.4 | 118.5 | 127.8 | 156.3 | 139.1 | 152.7 | 167.6 | 183.9 | 201.8 |
| Inventories, % | 4.42 | 6.39 | 6.69 | 6.25 | 7.78 | 6.31 | 6.31 | 6.31 | 6.31 | 6.31 |
| Accounts Payable | 20.2 | 52.2 | 184.0 | 63.5 | 266.2 | 140.0 | 153.6 | 168.6 | 185.0 | 203.0 |
| Accounts Payable, % | 1.44 | 3.54 | 10.39 | 3.11 | 13.24 | 6.34 | 6.34 | 6.34 | 6.34 | 6.34 |
| Capital Expenditure | -52.3 | -339.0 | -125.6 | -272.4 | -234.8 | -259.4 | -284.7 | -312.4 | -342.8 | -376.3 |
| Capital Expenditure, % | -3.73 | -22.96 | -7.09 | -13.32 | -11.68 | -11.76 | -11.76 | -11.76 | -11.76 | -11.76 |
| Tax Rate, % | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 |
| EBITAT | 368.8 | 421.3 | 500.3 | 578.1 | 639.7 | 631.9 | 693.5 | 761.1 | 835.2 | 916.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -367.5 | -220.2 | 729.0 | 255.7 | 920.4 | -97.3 | 395.4 | 433.9 | 476.2 | 522.6 |
| WACC, % | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1,340.3 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 541 | |||||||||
| Terminal Value | 15,062 | |||||||||
| Present Terminal Value | 10,693 | |||||||||
| Enterprise Value | 12,033 | |||||||||
| Net Debt | 1,116 | |||||||||
| Equity Value | 10,917 | |||||||||
| Diluted Shares Outstanding, MM | 530 | |||||||||
| Equity Value Per Share | 20.59 |
Benefits You Will Receive
- Comprehensive Financial Model: Leverage Tibet Cheezheng's actual data for accurate DCF valuations.
- Complete Forecast Customization: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Automatic updates allow you to view results instantly as adjustments are made.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
- Flexible and Reusable: Designed for versatility, enabling repeated use for in-depth forecasts.
Key Features
- Authentic Tibetan Medicine Data: Pre-loaded with Tibet Cheezheng’s historical performance metrics and projections for future growth.
- Customizable Assumptions: Tailor inputs such as revenue growth, profit margins, discount rates, tax brackets, and capital investments.
- Advanced Valuation Framework: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your customized parameters.
- Multi-Scenario Analysis: Develop various forecasting scenarios to evaluate potential valuation variations.
- Intuitive Interface: Designed for ease of use, suitable for both seasoned professionals and newcomers to the field.
How It Functions
- Download the Template: Gain immediate access to the Excel-based Tibet Cheezheng DCF Calculator for [002287SZ].
- Enter Your Assumptions: Modify the yellow-highlighted cells to adjust growth rates, WACC, profit margins, and more.
- Automatic Calculations: The model instantaneously updates the intrinsic value of Tibet Cheezheng.
- Explore Scenarios: Test various assumptions to see how they affect potential valuations.
- Evaluate and Decide: Use the outcomes to inform your investment strategies or financial assessments.
Why Choose Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287SZ)?
- Time-Efficient: Skip the lengthy processes – our solutions are ready for immediate application.
- Enhanced Precision: Dependable data and methodologies minimize valuation errors.
- Completely Adaptable: Modify the model to align with your specific assumptions and forecasts.
- Simple to Understand: Intuitive charts and outputs facilitate straightforward analysis.
- Endorsed by Professionals: Crafted for experts who prioritize accuracy and functionality.
Who Can Benefit from Our Products?
- Tibetan Medicine Practitioners: Enhance your practice with our authentic formulations based on traditional techniques.
- Researchers: Integrate our products into your studies on the efficacy of Tibetan herbal medicine.
- Health Enthusiasts: Explore the benefits of our natural remedies and their impact on wellness.
- Merchants: Access our diverse range of Tibetan medicine products to broaden your inventory.
- Consumers: Discover how our remedies can complement your health regimen.
Contents of the Template
- Historical Data: Contains past financial performance and baseline projections for Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287SZ).
- DCF and Levered DCF Models: Comprehensive templates designed to assess the intrinsic value of Tibet Cheezheng (002287SZ).
- WACC Sheet: Pre-configured computations for the Weighted Average Cost of Capital.
- Editable Inputs: Adjust essential parameters such as growth rates, EBITDA percentages, and CAPEX estimates.
- Quarterly and Annual Statements: Detailed analysis of Tibet Cheezheng's financial documents.
- Interactive Dashboard: Tools to dynamically visualize valuation outcomes and forecasts.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.